Miljenko Dorić
About
In The Last Decade
Miljenko Dorić
23 papers receiving 599 citations
Peers
Comparison fields: 5 of 79
- Endocrinology 320
- Molecular Biology 261
- Immunology 224
- Infectious Diseases 89
- Food Science 87
Countries citing papers authored by Miljenko Dorić
This map shows the geographic impact of Miljenko Dorić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miljenko Dorić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miljenko Dorić more than expected).
Fields of papers citing papers by Miljenko Dorić
This network shows the impact of papers produced by Miljenko Dorić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miljenko Dorić. The network helps show where Miljenko Dorić may publish in the future.
Co-authorship network of co-authors of Miljenko Dorić
This figure shows the co-authorship network connecting the top 25 collaborators of Miljenko Dorić. A scholar is included among the top collaborators of Miljenko Dorić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miljenko Dorić. Miljenko Dorić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 72 | |
| 3 | 30 | |
| 4 | 13 | |
| 5 | Systemic Character of Legionnaires’ Disease – A Murine Model | 1 |
| 6 | 43 | |
| 7 | 17 | |
| 8 | 4 | |
| 9 | 34 | |
| 10 | 69 | |
| 11 | 38 | |
| 12 | 102 | |
| 13 | 29 | |
| 14 | 42 | |
| 15 | 14 | |
| 16 | Antimicrobial activity and immunological side effects of different antibiotics. | 1 |
| 17 | 2 | |
| 18 | 7 | |
| 19 | 25 | |
| 20 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.